Recro Pharma: 2Q Earnings Snapshot

August 7, 2018

MALVERN, Pa. (AP) _ Recro Pharma Inc. (REPH) on Tuesday reported a loss of $12.7 million in its second quarter.

The Malvern, Pennsylvania-based company said it had a loss of 62 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.35 per share.

The specialty pharmaceutical company posted revenue of $21.7 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $16.8 million.

Recro Pharma shares have dropped 40 percent since the beginning of the year. The stock has fallen 27 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REPH at https://www.zacks.com/ap/REPH

Update hourly